orofacial pain

FDA OKs new drug to treat thyroid cancer

The U.S. Food and Drug Administration (FDA) has approved vandetanib to treat adult patients with late-stage medullary thyroid cancer who are ineligible for surgery and

Buccal beats lingual for numbing first molars

Buccal infiltration is more effective than lingual infiltration in obtaining anesthesia of the first mandibular molar and premolar teeth, according to researchers from the Newcastle

Novalar to cease operations

Following its announcement last week that it had sold its only commercial product to Septodont, Novalar is on the verge of shutting down completely, according

Septodont acquires OraVerse from Novalar

Septodont has acquired the OraVerse product line from Novalar Pharmaceuticals, the companies announced today. OraVerse is the first local anesthesia reversal agent to gain U.S.

Heraeus updates Gluma desensitizing product

Heraeus has launched Gluma Desensitizer PowerGel, a new one-step gel formula desensitizer that allows for accurate control and placement to reduce or eliminate dentinal hypersensitivity.

WhatsApp